How to Track GLP-1 Doses and Side Effects
[GLP-1 · Tracking]

How to Track GLP-1 Doses and Side Effects: What to Log and Why

Dose time · mg · Site · Open date · Lot · Side effects · Weight

A good GLP-1 log answers four questions fast: what did I take, when, where did I inject it, and how did I feel afterward. That sounds basic, but the labels for these drugs are full of rules that depend on exactly those details. Missed-dose windows are counted in days and hours. Dose steps happen every 4 weeks. Pens and vials have use-by limits that start on the day you first open them. And the side effects that matter most to your prescriber are the ones that last or get worse.

This guide lists what to write down and why, using the FDA labels for Ozempic, Wegovy and Zepbound as the reference. It works the same on paper, in a notes app or in a tracker.

The short list

Log thisWhy it matters
Date and time of each shotMissed-dose and day-change rules are counted in days and hours
Dose in mgDose steps happen every 4 weeks; mg is the unit on every label
Injection siteAll three labels say to rotate sites
Pen or vial, open date, lot numberIn-use limits start at first use; the lot helps if you report a problem
Side effects, with a 1-to-5 ratingSevere or lasting stomach symptoms are something the labels say to report
Skipped or late doses, with the reasonSeveral missed doses in a row can change how you restart
Weight, once a weekShows the trend your prescriber looks at when choosing a maintenance dose

1. Date and time of every dose

These are weekly shots, so it is easy to lose track of whether the last one was Sunday or Monday. The exact day matters, because each label gives a window for a late dose, and the windows are not the same:

  • Ozempic: take a missed dose within 5 days. After 5 days, skip it and go back to your usual day. You can change your shot day if the two doses are at least 2 days (more than 48 hours) apart (Ozempic label, 2.1).
  • Wegovy injection: if the next dose is more than 2 days away, take the missed one as soon as you can. If it is less than 2 days away, skip it. If you miss 2 or more doses in a row, the label says to restart the dose steps at a lower dose (Wegovy label, 2.4).
  • Zepbound (tirzepatide): take a missed dose within 4 days (96 hours). After that, skip it. You can change your shot day if the doses are at least 3 days (72 hours) apart (Zepbound label, 2.3).

Without a time stamp you are guessing at those hours. With one, the answer is simple subtraction. Our missed-dose pages for Ozempic, Wegovy, Mounjaro and Zepbound walk through each rule.

2. The dose, in milligrams

Every GLP-1 label starts low and steps up. Zepbound starts at 2.5 mg for 4 weeks, then goes to 5 mg, and can rise in 2.5 mg steps after at least 4 weeks on each dose, up to a maximum of 15 mg. The label notes that 2.5 mg is a starting dose only, not a maintenance dose (Zepbound label, 2.1 and 2.2). Wegovy steps up every 4 weeks from 0.25 mg through 0.5, 1 and 1.7 mg to a maintenance dose from week 17 (Wegovy label, 2.2).

Both labels say the slow climb is there to lower the risk of stomach side effects. The Wegovy label adds that if a dose isn't tolerated, the prescriber can consider holding the next step for 4 weeks (Wegovy label, 2.2). Writing down the date of each step makes it clear when the next one is due, and lets you match side effects to a specific dose change.

Always log in mg, even if you draw from a vial with a syringe. Units on a syringe depend on the vial's strength, so "20 units" means nothing on its own. If you use a compounded vial, our semaglutide and tirzepatide units charts convert mg to syringe units for common strengths.

3. Where you injected

All three labels say to rotate injection sites with each dose. The Ozempic label says to use a different site each week when you inject in the same body area (Ozempic label, 2.1; Wegovy label, 2.1; Zepbound label, 2.4). The approved areas are the belly, thigh and upper arm (for Zepbound, the back of the upper arm when someone else gives the shot).

A site log is the only reliable way to rotate. It also helps if you notice a lump, redness or itching, because you can see which shot caused it. Our guide to injection site rotation covers why repeated use of one spot can cause problems.

4. Which pen or vial, when you opened it, and the lot number

Pens and vials do not last forever once opened, and the clock starts on first use:

  • An Ozempic pen can be stored for 56 days after first use, at room temperature (59°F to 86°F) or in the fridge (Ozempic label, 16).
  • A Wegovy FlexTouch pen can be stored for 56 days after first use. Wegovy single-dose pens hold one dose and are thrown away after use (Wegovy label, 16).
  • An opened Zepbound multi-dose vial or KwikPen is thrown away after 30 days at room temperature, 30 days after first use, or after 4 weekly doses, even if there is medicine left (Zepbound label, 16).

Write down the date you open each one, so you know when it must go. The lot number, printed on the carton and the pen or vial, is worth recording too. If something seems wrong with a product, it is the detail the FDA's reporting form and the maker will ask for.

5. Side effects, rated, with the date

Stomach and gut symptoms are the most common side effects of these drugs. In the Wegovy weight trials at 2.4 mg, nausea was reported by 44% of people versus 16% on placebo (Wegovy label, 6.1). Most people will have something to log, especially around dose steps.

A useful side-effect entry has four parts: what it was, how bad (a 1-to-5 scale works), when it started relative to your shot, and how long it lasted. "Nausea, 3 out of 5, started day 2 after the 5 mg step, gone by day 4" tells your prescriber far more than "felt sick this week."

The labels name the symptoms worth reporting quickly. The Zepbound label tells patients to contact their healthcare provider for severe or lasting stomach symptoms, to take steps to avoid losing too much fluid, and to report nausea, vomiting or diarrhea that goes on and on, because dehydration can harm the kidneys. It also lists severe belly pain that may spread to the back as a possible sign of pancreatitis, and a lump in the neck, lasting hoarseness, trouble swallowing or shortness of breath as possible thyroid tumor symptoms (Zepbound label, 17). If you have any of these, don't wait for your next visit. Call your prescriber.

If you also take insulin or a sulfonylurea for diabetes, the Ozempic label warns that the combination can raise the risk of low blood sugar (Ozempic label, 5.5). Logging low readings and how you felt gives your care team what they need to adjust things.

For more on what to expect, see our guides to GLP-1 side effects over time and nausea on GLP-1s.

6. Skipped and late doses

A skipped dose is data too. Write down that you skipped it and why: travel, side effects, forgot, or ran out. Two reasons this helps:

  • The Wegovy label treats 2 or more missed doses in a row differently from a single miss (Wegovy label, 2.4). A clear record shows which case you are in.
  • If you keep skipping because of side effects, that is a pattern your prescriber needs to see. It may affect which maintenance dose makes sense for you.

7. Weight, on a steady schedule

Day-to-day weight jumps around. Weighing once a week, on the same day and at the same time, makes the trend easier to read. The labels ask prescribers to consider your response and how well you tolerate the drug when choosing a maintenance dose (Zepbound label, 2.1; Wegovy label, 2.2), and a weekly weight log next to your dose history shows both.

How to report a side effect to the FDA

Anyone can report a side effect or a product problem to the FDA through MedWatch, the FDA's safety reporting program for health professionals, patients and consumers. The labels also print the FDA's reporting phone number, 1-800-FDA-1088 (Ozempic label, highlights). Reporting is separate from calling your prescriber: do both if something serious happens. Your log makes the report much easier, since you'll have the dates, doses, lot number and symptoms in one place.

Bringing your log to an appointment

Prescribers have limited time, so give them a summary rather than every entry:

  • Your current dose and the date you started it.
  • Any missed or late doses since the last visit.
  • The two or three side effects that bothered you most, with how bad they were and how long they lasted.
  • Your weight trend since the last visit.
  • Any other medicines you started. GLP-1s slow stomach emptying, and the labels say this may affect how well some pills are absorbed (Ozempic label, 7.2).

How Dose Track handles this

Dose Track was built for this kind of log, including when you take more than one compound. A few specifics, all described in our help center:

  • Logging a dose: tap + on the medication and the log sheet opens with your dose and a suggested injection site filled in. You can log on another day from the Calendar, and record a skipped dose with a reason (traveling, side effects, forgot, or other). See how to log a dose.
  • Site rotation: the app suggests the site that has rested longest and warns you if you pick one used too recently. See injection site rotation.
  • Side effects: from a dose in the Calendar, Log Side Effects lets you note a reaction to that dose. The daily check-in lets you rate things like energy, sleep and hunger from 1 to 5. See editing a dose and the daily check-in.
  • Vials and supplies: each logged dose comes out of the open vial, you can record the lot or batch, and the app can remind you to reorder before you run out. See vials and inventory and run-out alerts.
  • Reminders: set a reminder time for each medication, with an optional follow-up if a dose isn't logged. See setting up reminders.
  • Weight: log it by hand or bring it in from Apple Health or Health Connect. See tracking weight.
  • Sharing with your prescriber: Export Med Log (CSV) makes a spreadsheet of date, medication and dose in mg. See exporting your data.

Whatever tool you use, the habit matters more than the app. Log the shot when you take it, and log a side effect the day you notice it, not a week later from memory. If you want to compare notes with other people on GLP-1s, the Dose Track community is open to everyone.

This article is general information, not medical advice. Talk to your prescriber before you start, change or stop any medicine.

Frequently asked questions

What should I track on a GLP-1 like Ozempic or Zepbound?+
Log the date and time of each shot, the dose in mg, the injection site, the pen or vial with its open date and lot number, any side effects with how bad they were and how long they lasted, skipped doses with the reason, and your weight once a week.
Why does the time of my shot matter if it is weekly?+
The labels give missed-dose windows in days and hours. Ozempic allows a late dose within 5 days, Zepbound within 4 days (96 hours), and Wegovy as long as the next dose is more than 2 days away. A time stamp lets you check where you are.
How long can I use an opened GLP-1 pen or vial?+
The labels say an Ozempic pen and a Wegovy FlexTouch pen can be stored for 56 days after first use. An opened Zepbound multi-dose vial or KwikPen is thrown away after 30 days at room temperature, 30 days after first use, or after 4 weekly doses, whichever comes first.
Which side effects should I report right away?+
The Zepbound label tells patients to contact their provider about severe or lasting stomach symptoms, nausea, vomiting or diarrhea that goes on and on (dehydration can harm the kidneys), severe belly pain that may spread to the back, and a neck lump, lasting hoarseness, trouble swallowing or shortness of breath. Call your prescriber if you have any of these.
How do I report a GLP-1 side effect to the FDA?+
Use MedWatch, the FDA safety reporting program, online at fda.gov/medwatch or by phone at 1-800-FDA-1088. Have the product name, dose, dates, lot number and a description of what happened ready.
Should I log doses in units or milligrams?+
Milligrams. Every label gives doses in mg, and syringe units depend on the strength of the vial, so the same number of units can mean different doses.

References

  1. Novo Nordisk. Ozempic (semaglutide) injection prescribing information, revised 05/2026. Sections 2.1, 5.5, 7.2, 16. https://www.novo-pi.com/ozempic.pdf
  2. Novo Nordisk. Wegovy (semaglutide) prescribing information, revised 06/2026. Sections 2.1, 2.2, 2.4, 6.1, 16. https://www.novo-pi.com/wegovy.pdf
  3. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information, revised 08/2026. Sections 2.1 to 2.4, 16, 17. https://pi.lilly.com/us/zepbound-uspi.pdf
  4. U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program